Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study
- PMID: 34876415
- PMCID: PMC8673484
- DOI: 10.9778/cmajo.20210085
Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study
Abstract
Background: Reports have suggested that anosmia is strongly associated with SARS-CoV-2 infection, but patients were often asked about this symptom after their diagnosis. This study assessed associations between prospectively reported anosmia and other symptoms related to SARS-CoV-2 infection, and SARS-CoV-2 positivity in community testing centres in Toronto, Ontario.
Methods: We conducted a retrospective cross-sectional study in which data were collected from 2 COVID-19 assessment centres affiliated with 2 hospitals in Toronto, Ontario, from Apr. 5 to Sept. 30, 2020. We included symptomatic profiles of all people who underwent a SARS-CoV-2 test at either clinic within the study period. We used generalized estimating equations to account for repeat visits and to assess associations between anosmia and other symptoms and SARS-CoV-2 positivity.
Results: A total of 83 443 SARS-CoV-2 tests were conducted across the 2 sites for 72 692 participants during the study period. Of all tests, 1640 (2.0%) were positive; 837 (51.0%) of people who tested positive were asymptomatic. The adjusted odds ratio for the association between anosmia and test positivity was 5.29 (95% confidence interval [CI] 4.50-6.22), with sensitivity of 0.138 (95% CI 0.121-0.154), specificity of 0.980 (95% CI 0.979-0.981), a positive predictive value of 0.120 (95% CI 0.106-0.135) and a negative predictive value of 0.983 (95% CI 0.982-0.984).
Interpretation: Anosmia had high specificity and a positive predictive value of 12% for SARS-CoV-2 infection in this community population with low prevalence of SARS-CoV-2 positivity. The presence of anosmia should increase clinical suspicion of SARS-CoV-2 infection, and our findings suggest that people presenting with this symptom should be tested.
© 2021 CMA Joule Inc. or its licensors.
Conflict of interest statement
Competing interests: Rebecca Stoller declares a stipend as medical lead for the North York General Hospital COVID-19 assessment centre. Michelle Greiver reports a grant to her department from Sanofi, GlaxoSmithKline and Novartis for the development of a severe asthma registry using electronic medical record data. Michelle Greiver is director of UTOPIAN (University of Toronto Practice-Based Research Network) and lead of POPLAR (Primary care Ontario Practice-based Learning and Research Network). No other competing interests were declared.
Figures



Similar articles
-
Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study.CMAJ Open. 2021 Mar 30;9(1):E302-E308. doi: 10.9778/cmajo.20200253. Print 2021 Jan-Mar. CMAJ Open. 2021. PMID: 33785478 Free PMC article.
-
The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.Clin Microbiol Infect. 2021 Apr;27(4):633.e9-633.e16. doi: 10.1016/j.cmi.2020.12.029. Epub 2021 Jan 6. Clin Microbiol Infect. 2021. PMID: 33421576 Free PMC article.
-
Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study.CMAJ. 2021 May 17;193(20):E723-E734. doi: 10.1503/cmaj.202608. Epub 2021 Apr 27. CMAJ. 2021. PMID: 33906966 Free PMC article.
-
Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis.Arch Pharm Res. 2021 Jul;44(7):725-740. doi: 10.1007/s12272-021-01344-4. Epub 2021 Jul 24. Arch Pharm Res. 2021. PMID: 34302637 Free PMC article.
-
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2023 Mar 10;41(11):1902-1910. doi: 10.1016/j.vaccine.2022.11.022. Epub 2023 Feb 10. Vaccine. 2023. PMID: 36775774 Review.
Cited by
-
Socioeconomic and immigration status and COVID-19 testing in Toronto, Ontario: retrospective cross-sectional study.BMC Public Health. 2022 May 29;22(1):1067. doi: 10.1186/s12889-022-13388-2. BMC Public Health. 2022. PMID: 35643450 Free PMC article.
-
Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.PLoS One. 2023 Aug 2;18(8):e0288285. doi: 10.1371/journal.pone.0288285. eCollection 2023. PLoS One. 2023. PMID: 37531338 Free PMC article.
References
-
- COVID-19 coronavirus pandemic. Worldometer. [accessed 2021 Nov. 18]. Available: https://www.worldometers.info/coronavirus/
-
- Coronavirus. Geneva: World Health Organization; [accessed 2020 Apr. 1]. Available https://www.who.int/health-topics/coronavirus#tab=tab_1.
-
- Loss of sense of smell as marker of COVID-19 infection. London (UK): ENT UK at the Royal College of Surgeons of England; [accessed 2021 Mar. 11]. Available: https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%2....
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous